Future efforts focusing on screening compounds that inhibit DGC activity, activate PDE activity, or sequester free c-di-GMP by combining tools of our sensor and fluorescence-activated cell sorting (FACS) could offer new insights for combating biofilm-associated diseases. Here, ALDH7A1 is linked to glycogen storage disease VI.